AR and benign prostatic hyperplasia: Growth factors such as insulin-like growth factor 1, epidermal growth factor (EGF), fibroblast growth factor, and vascular endothelial growth factor (VEGF) are activated when DHT binds to androgen receptors, which may cause prostatic enlargement and the development of BPH [5,6].